RecruitingMajor Depressive Disorder (MDD)
Mechanisms Of Orbitofrontal Stimulation in Depression
Eligible age
18–65 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The orbitofrontal cortex (OFC), a region involved in emotional regulation, decision making, and reward processing, is a key area linked to antidepressant response. This study tests whether noninvasive stimulation of the OFC using transcranial magnetic stimulation (TMS) can improve depressive symptoms. TMS uses magnetic fields generated by a coil placed next to the scalp to alter brain activity.
Sponsor: Subha Subramanian
You may qualify if…
- ✓ Age 18-65 years
- ✓ Must be able to read, speak and understand English
- ✓ DSM-5 diagnosis of major depressive disorder, experiencing a moderate to severe depressive episode (Hamilton Depression Rating Scale score greater than or equal to 17 points)
- ✓ Must be judged by study staff to be capable of completing the study procedures
- ✓ Participants will be in stable outpatient treatment with no recent (within the past 30 days) hospitalizations or changes in their medication regimens
You may not qualify if…
- ✕ DSM-5 moderate to severe substance use disorder within the past three months, based on Structured Clinical Interview for DSM-5
- ✕ Conditions that might result in increased risks of side effects or complications from rTMS or MRI, including:
- ✕ History of fainting spells of unknown or undetermined etiology that might constitute seizures
- ✕ Diagnosis of epilepsy with the exception of a single seizure of benign etiology (e.g., febrile seizures) in the judgment of a board-certified neurologist
- ✕ Current or past history of a neurological disorder, such as stroke, a progressive neurologic disease, or intracranial brain lesion(s); and history of previous neurosurgery or head trauma that resulted in residual neurologic impairment
- ✕ Any unstable medical condition
- ✕ Any metal in the brain or skull (excluding dental fillings) unless cleared by the responsible covering MD
- ✕ Any devices which could be affected by TMS or MRI such as a pacemaker, medication pump, nerve stimulator, cochlear implant, TENS unit, ventriculo-peritoneal shunt unless cleared by the responsible covering MD
Where it's recruiting
Massachusetts
Boston
Source: ClinicalTrials.gov · NCT07230990 · last updated 2026-05-14